Loading, please wait ...


News Analytics

ded7059c 68eb 41bf a7b6 07a6f57b9c45?size=1.
VANCOUVER, British Columbia, Jan. 06, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical-stage pharmaceutical company, is pleased to announce that it has engaged Image Analysis Group (“IAG”), a leading medical imaging company, to provide important critical imaging services during the Berubicin phase 2 clinical trials which are scheduled to start in February 2021.
Google

Subject Matter

  • Science and technology 49.32%
  • Business, economics, society 26.03%
    • Companies, industries, organizations 100.00%
  • Healthcare 24.66%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions